Noevir Holdings Co.,Ltd.
| Market Cap | 155.1B |
| P/E Ratio | - |
| P/B Ratio | - |
| EPS | 235.10 |
| Dividend Yield | - |
| D/E Ratio | 0.41 |
| Current Ratio | 4.96 |
| Market Segment | Prime |
| Accounting | Japan GAAP |
| Currency | JPY |
Business Overview
Noevir Holdings Co., Ltd. develops, produces, and sells cosmetics, toiletries, medical supplies, and food products in China, Taiwan, South Korea, Hong Kong, Singapore, Thailand, the United States, and Canada. The company's Cosmetics segment develops, produces, and sells skincare products under various brands, including Noevir and Nameraka Honpo; excel make up line products and NOV hypoallergenic cosmetics, as well as provides contract manufacturing services for cosmetics and quasi drugs. Its Pharmaceutical and food business segment produces and sells Nanten Nodo Ame cough drops; functional drinks, such as the Min Min Da Ha; and over-the-counter pharmaceuticals comprising cold remedies, eye drops, and digestive aids, as well as nutritional supplements, and other products. The company's Other segment sells and leases apparel, body fashion, aircraft and ships, air transportation and pilot training business, etc. The company also provides market research. The company sells its products through drug stores and variety stores, and dermatology and medical institutions, as well as Noevir beauty studios and own retail stores. Noevir Holdings Co., Ltd. was founded in 1964 and is headquartered in Kobe, Japan.
Key Financial Metrics
Profitability
Returns & Efficiency
Financial Health
| Industry | RAW MATERIALS & CHEMICALS |
| Market Segment | Prime |
| Accounting | Japan GAAP |
| Currency | JPY |
| Fiscal Year | 2025 |
Stock Chart
Full charting with technical indicators, candlestick, line charts, and more.
Company Profile
| Company Name | Noevir Holdings Co.,Ltd. |
| Ticker | 4928 |
| Exchange | TSE |
| Sector | Chemicals |
| Industry | RAW MATERIALS & CHEMICALS |
| Market Segment | Prime |
| Accounting | Japan GAAP |
| Fiscal Year | 2025 |
| Currency | JPY |
| Market Cap | 155.1B |
| Revenue | 64.7B |
| Net Income | 8.0B |
| P/E Ratio | - |
| EPS | 235.10 |
| Net Margin | 12.4% |
| ROE | 14.8% |
| Dividend Yield | - |
Noevir Holdings Co., Ltd. develops, produces, and sells cosmetics, toiletries, medical supplies, and food products in China, Taiwan, South Korea, Hong Kong, Singapore, Thailand, the United States, and Canada. The company's Cosmetics segment develops, produces, and sells skincare products under various brands, including Noevir and Nameraka Honpo; excel make up line products and NOV hypoallergenic cosmetics, as well as provides contract manufacturing services for cosmetics and quasi drugs. Its Pharmaceutical and food business segment produces and sells Nanten Nodo Ame cough drops; functional drinks, such as the Min Min Da Ha; and over-the-counter pharmaceuticals comprising cold remedies, eye drops, and digestive aids, as well as nutritional supplements, and other products. The company's Other segment sells and leases apparel, body fashion, aircraft and ships, air transportation and pilot training business, etc. The company also provides market research. The company sells its products through drug stores and variety stores, and dermatology and medical institutions, as well as Noevir beauty studios and own retail stores. Noevir Holdings Co., Ltd. was founded in 1964 and is headquartered in Kobe, Japan.